These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30565989)

  • 1. Timing of Intervention in Non-ST Elevation Acute Coronary Syndromes.
    Jolly SS; Mehta SR
    Circulation; 2018 Dec; 138(24):2751-2753. PubMed ID: 30565989
    [No Abstract]   [Full Text] [Related]  

  • 2. Behind the Times?: Optimal Timing of an Invasive Strategy in Non-ST-Segment Elevation Acute Coronary Syndromes.
    O'Donoghue ML; Bergmark BA
    JACC Cardiovasc Interv; 2018 Feb; 11(4):381-383. PubMed ID: 29471952
    [No Abstract]   [Full Text] [Related]  

  • 3. Sex Differences in Percutaneous Coronary Intervention-Insights From the Coronary Angiography and PCI Registry of the German Society of Cardiology.
    Heer T; Hochadel M; Schmidt K; Mehilli J; Zahn R; Kuck KH; Hamm C; Böhm M; Ertl G; Hoffmeister HM; Sack S; Senges J; Massberg S; Gitt AK; Zeymer U
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28320749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Invasive Versus Initial Conservative Strategies for Women with Non-ST-Elevation Acute Coronary Syndromes: A Nationwide Analysis.
    Elgendy IY; Mahmoud AN; Mansoor H; Bavry AA
    Am J Med; 2017 Sep; 130(9):1059-1067. PubMed ID: 28238691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optical Coherence Tomography to Optimize Results of Percutaneous Coronary Intervention in Patients with Non-ST-Elevation Acute Coronary Syndrome: Results of the Multicenter, Randomized DOCTORS Study (Does Optical Coherence Tomography Optimize Results of Stenting).
    Meneveau N; Souteyrand G; Motreff P; Caussin C; Amabile N; Ohlmann P; Morel O; Lefrançois Y; Descotes-Genon V; Silvain J; Braik N; Chopard R; Chatot M; Ecarnot F; Tauzin H; Van Belle E; Belle L; Schiele F
    Circulation; 2016 Sep; 134(13):906-17. PubMed ID: 27573032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Access Site on Bleeding and Ischemic Events in Patients With Non-ST-Segment Elevation Myocardial Infarction Treated With Prasugrel: The ACCOAST Access Substudy.
    Porto I; Bolognese L; Dudek D; Goldstein P; Hamm C; Tanguay JF; Ten Berg J; Widimský P; Le Gall N; Zagar AJ; LeNarz LA; Miller D; Montalescot G;
    JACC Cardiovasc Interv; 2016 May; 9(9):897-907. PubMed ID: 27151605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of Percutaneous Coronary Intervention in Non-ST-Segment-Elevation Myocardial Infarction Patients With or Without Prior Coronary Bypass.
    Alkhouli M; Mathew V
    Circ Cardiovasc Interv; 2018 Nov; 11(11):e007460. PubMed ID: 30571220
    [No Abstract]   [Full Text] [Related]  

  • 8. Different perspectives on outcomes in patients with non-ST-elevation myocardial infarction when observed in clinical trials and in real life.
    Wallentin L
    Eur Heart J; 2018 Nov; 39(42):3821-3824. PubMed ID: 30339178
    [No Abstract]   [Full Text] [Related]  

  • 9. Very early invasive strategy in patients with non-ST-elevation myocardial infarction: should we go for it?
    Lemesle G; Schurtz G; Verdier B; Bonello L
    Heart; 2024 Mar; 110(7):461-462. PubMed ID: 38103914
    [No Abstract]   [Full Text] [Related]  

  • 10. Relationship Between β-Blocker Therapy at Discharge and Clinical Outcomes in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    Li C; Sun Y; Shen X; Yu T; Li Q; Ruan G; Zhang L; Huang Q; Zhuang H; Huang J; Ni L; Wang L; Jiang J; Wang Y; Wang DW
    J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27852588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing Acute Coronary Syndromes in Older Adults With Chronic Kidney Disease: Are We There Yet?
    Kayani WT; Tanavin T; Jneid H
    J Am Heart Assoc; 2020 Jun; 9(12):e016909. PubMed ID: 32519562
    [No Abstract]   [Full Text] [Related]  

  • 12. COVID-19 pandemic: National outbreak and acute coronary syndrome. Collateral damages?
    López-Palop R; Lozano Í; Carrillo P
    Int J Cardiol; 2023 Mar; 375():144-146. PubMed ID: 36493929
    [No Abstract]   [Full Text] [Related]  

  • 13. Heparin monotherapy or bivalirudin during percutaneous coronary intervention in patients with non-ST-segment-elevation acute coronary syndromes or stable ischemic heart disease: results from the Evaluation of Drug-Eluting Stents and Ischemic Events registry.
    Bangalore S; Pencina MJ; Kleiman NS; Cohen DJ
    Circ Cardiovasc Interv; 2014 Jun; 7(3):365-73. PubMed ID: 24736878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reperfusion strategies in acute coronary syndromes.
    Bagai A; Dangas GD; Stone GW; Granger CB
    Circ Res; 2014 Jun; 114(12):1918-28. PubMed ID: 24902975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of Initial Revascularization Versus Medical Therapy Alone in Patients With Non-ST-Segment-Elevation Acute Coronary Syndrome Undergoing an Invasive Strategy.
    Wijeysundera HC; Sidhu MS; Bennell MC; Qiu F; Ko DT; Knudtson ML; Tu JV; Boden WE
    Circ Cardiovasc Interv; 2016 Jul; 9(7):. PubMed ID: 27418612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics, Management, and Outcome of Transient ST-elevation Versus Persistent ST-elevation and Non-ST-elevation Myocardial Infarction.
    Blondheim DS; Kleiner-Shochat M; Asif A; Kazatsker M; Frimerman A; Abu-Fanne R; Neiman E; Barel M; Levy Y; Amsalem N; Shotan A; Meisel SR
    Am J Cardiol; 2018 Jun; 121(12):1449-1455. PubMed ID: 29699746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated Clotting Time to Guide Heparin Dosing in Non-ST-Segment-Elevation Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention and Treated With IIb/IIIa Inhibitors: Impact on Ischemic and Bleeding Outcomes: Insights From the TAO Trial.
    Dillinger JG; Ducrocq G; Elbez Y; Cohen M; Bode C; Pollack C; Nicolau JC; Henry P; Kedev S; Wiviott SD; Sabatine MS; Mehta SR; Steg PG
    Circ Cardiovasc Interv; 2018 Jun; 11(6):e006084. PubMed ID: 29895599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal Timing of Complete Revascularization in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis.
    Gaffar R; Habib B; Filion KB; Reynier P; Eisenberg MJ
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28396570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic implications of mean platelet volume on short- and long-term outcomes among patients with non-ST-segment elevation myocardial infarction treated with percutaneous coronary intervention: A single-center large observational study.
    Wasilewski J; Desperak P; Hawranek M; Ciślak A; Osadnik T; Pyka Ł; Gawlita M; Bujak K; Niedziela J; Krawczyk M; Gąsior M
    Platelets; 2016 Jul; 27(5):452-8. PubMed ID: 26939525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute Myocardial Infarction: Changes in Patient Characteristics, Management, and 6-Month Outcomes Over a Period of 20 Years in the FAST-MI Program (French Registry of Acute ST-Elevation or Non-ST-Elevation Myocardial Infarction) 1995 to 2015.
    Puymirat E; Simon T; Cayla G; Cottin Y; Elbaz M; Coste P; Lemesle G; Motreff P; Popovic B; Khalife K; Labèque JN; Perret T; Le Ray C; Orion L; Jouve B; Blanchard D; Peycher P; Silvain J; Steg PG; Goldstein P; Guéret P; Belle L; Aissaoui N; Ferrières J; Schiele F; Danchin N;
    Circulation; 2017 Nov; 136(20):1908-1919. PubMed ID: 28844989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.